State of Alaska Department of Revenue Sells 719 Shares of Select Medical Holdings Co. (NYSE:SEM)

State of Alaska Department of Revenue lowered its stake in shares of Select Medical Holdings Co. (NYSE:SEM) by 1.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 59,381 shares of the health services provider’s stock after selling 719 shares during the period. State of Alaska Department of Revenue’s holdings in Select Medical were worth $1,119,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Point72 Asset Management L.P. lifted its stake in shares of Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the period. Loomis Sayles & Co. L P bought a new position in shares of Select Medical in the 3rd quarter worth approximately $9,710,000. LMR Partners LLP bought a new position in shares of Select Medical in the 3rd quarter worth approximately $6,139,000. Barclays PLC lifted its stake in shares of Select Medical by 396.0% in the 3rd quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock worth $6,707,000 after purchasing an additional 153,576 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in shares of Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after purchasing an additional 147,032 shares during the period. Institutional investors own 89.48% of the company’s stock.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Select Medical Trading Down 3.8 %

Select Medical stock opened at $18.25 on Thursday. The firm has a 50 day moving average of $19.30 and a 200 day moving average of $28.90. The firm has a market capitalization of $2.36 billion, a price-to-earnings ratio of 8.53, a P/E/G ratio of 0.65 and a beta of 1.45. Select Medical Holdings Co. has a 12-month low of $18.02 and a 12-month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on SEM. Royal Bank of Canada increased their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. UBS Group lowered their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Monday, January 27th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $39.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.